|
2025-02-26 |
2025-02-25 |
V
Vente
|
Decker Robert J
VP Corporate Controller
Dirigeant
|
6 999
-25.0%
165,88
1 160 994 USD
|
6 999
-25.0%
|
165,88
|
1 160 994 USD
|
|
|
2025-02-18 |
2025-02-18 |
V
Vente
|
Schmid Timothy
EVP, WW Chair, MedTech
Dirigeant
|
403
-2.6%
156,15
62 928 USD
|
403
-2.6%
|
156,15
|
62 928 USD
|
|
|
2025-02-11 |
2025-02-07 |
V
Vente
|
Wolk Joseph J
Exec VP, CFO
Dirigeant
|
13 015
-100.0%
153,89
2 002 878 USD
|
13 015
-100.0%
|
153,89
|
2 002 878 USD
|
|
|
2024-12-12 |
2024-12-12 |
A
Achat
|
WEINBERGER MARK A
Administrateur non-exécutif
|
1 000
+inf%
147,22
147 220 USD
|
1 000
+inf%
|
147,22
|
147 220 USD
|
|
|
2024-09-03 |
2024-08-30 |
V
Vente
|
Decker Robert J
VP Corporate Controller
Dirigeant
|
5 635
-22.9%
165,06
930 113 USD
|
5 635
-22.9%
|
165,06
|
930 113 USD
|
|
|
2024-03-13 |
2024-03-13 |
V
Vente
|
Broadhurst Vanessa
EVP, Global Corp Affairs
Dirigeant
|
8 891
-37.1%
162,16
1 441 765 USD
|
8 891
-37.1%
|
162,16
|
1 441 765 USD
|
|
|
2024-02-12 |
2024-02-09 |
V
Vente
|
Taubert Jennifer L
EVP, WW Chair, Pharmaceuticals
Dirigeant
|
59 397
-29.6%
156,27
9 281 969 USD
|
59 397
-29.6%
|
156,27
|
9 281 969 USD
|
|
|
2023-07-27 |
2023-07-26 |
V
Vente
|
Hait William
See Remarks
Dirigeant
|
14 698
-14.3%
172,00
2 528 056 USD
|
14 698
-14.3%
|
172,00
|
2 528 056 USD
|
|
|
2023-07-27 |
2023-07-25 |
V
Vente
|
Fasolo Peter
Exec VP, Chief HR Officer
Dirigeant
|
20 000
-16.3%
170,32
3 406 498 USD
|
20 000
-16.3%
|
170,32
|
3 406 498 USD
|
|
|
2023-06-14 |
2023-06-12 |
V
Vente
|
Wengel Kathryn E
EVP, Chief TO and Risk Officer
Dirigeant
|
12 465
-15.9%
160,00
1 994 400 USD
|
12 465
-15.9%
|
160,00
|
1 994 400 USD
|
|
|
2023-03-08 |
2023-03-06 |
V
Vente
|
Swanson James D.
See Remarks
Dirigeant
|
1 062
-10.3%
154,66
164 199 USD
|
1 062
-10.3%
|
154,66
|
164 199 USD
|
|
|
2022-12-15 |
2022-12-13 |
V
Vente
|
Wolk Joseph J
Exec VP, CFO
Dirigeant
|
12 926
-26.5%
179,62
2 321 755 USD
|
12 926
-26.5%
|
179,62
|
2 321 755 USD
|
|
|
2022-12-15 |
2022-12-13 |
V
Vente
|
Wolk Joseph J
Exec VP, CFO
Dirigeant
|
1 855
-3.7%
179,46
332 906 USD
|
1 855
-3.7%
|
179,46
|
332 906 USD
|
|
|
2022-12-02 |
2022-11-30 |
V
Vente
|
McEvoy Ashley
EVP, WW Chair, MedTech
Dirigeant
|
71 923
-63.2%
175,46
12 619 272 USD
|
71 923
-63.2%
|
175,46
|
12 619 272 USD
|
|
|
2022-12-02 |
2022-11-30 |
V
Vente
|
McEvoy Ashley
EVP, WW Chair, MedTech
Dirigeant
|
1 400
-1.2%
176,09
246 529 USD
|
1 400
-1.2%
|
176,09
|
246 529 USD
|
|
|
2022-11-23 |
2022-11-22 |
V
Vente
|
Taubert Jennifer L
EVP, WW Chair, Pharmaceuticals
Dirigeant
|
76 923
-37.8%
176,78
13 598 402 USD
|
76 923
-37.8%
|
176,78
|
13 598 402 USD
|
|
|
2022-11-21 |
2022-11-18 |
V
Vente
|
Decker Robert J
Controller, CAO
Dirigeant
|
16 928
-52.2%
175,00
2 962 400 USD
|
16 928
-52.2%
|
175,00
|
2 962 400 USD
|
|
|
2022-11-10 |
2022-11-09 |
V
Vente
|
Wengel Kathryn E
EVP, Chief GSC Officer
Dirigeant
|
16 410
-18.7%
173,42
2 845 773 USD
|
16 410
-18.7%
|
173,42
|
2 845 773 USD
|
|
|
2022-11-08 |
2022-11-04 |
V
Vente
|
Mongon Thibaut
Exec VP, WW Chair, Consumer
Dirigeant
|
18 293
-31.3%
171,22
3 132 036 USD
|
18 293
-31.3%
|
171,22
|
3 132 036 USD
|
|
|
2022-11-08 |
2022-11-04 |
V
Vente
|
Mongon Thibaut
Exec VP, WW Chair, Consumer
Dirigeant
|
16 953
-22.5%
171,14
2 901 269 USD
|
16 953
-22.5%
|
171,14
|
2 901 269 USD
|
|
